...
首页> 外文期刊>Case Reports in Oncology >Esophageal Metastasis to the Iris Effectively Palliated Using Stereotactic Body Radiation Therapy and Adjuvant Intravitreal Chemotherapy: Case Report and Literature Review
【24h】

Esophageal Metastasis to the Iris Effectively Palliated Using Stereotactic Body Radiation Therapy and Adjuvant Intravitreal Chemotherapy: Case Report and Literature Review

机译:立体定向放射治疗和玻璃体内辅助化疗有效缓解虹膜食管转移:病例报告和文献复习

获取原文

摘要

We report a case of isolated iris metastasis from esophageal adenocarcinoma that was successfully managed with local application of stereotactic body radiation therapy (SBRT) and adjunctive intravitreal therapy. A 53-year-old man with locally advanced esophageal adenocarcinoma achieved a complete clinical and radiographic response after surgery and chemotherapy. Four months later, he developed headache and decreased vision and was diagnosed with metastasis to the iris by slit-lamp examination. The decrease in vision was secondary to cystoid macular edema. The metastatic tumor and the patient’s symptoms resolved after treatment with SBRT and intravitreal injections of bevacizumab and triamcinolone. We conclude that SBRT combined with intravitreal chemotherapy is an effective and well-tolerated palliative treatment for metastasis of esophageal adenocarcinoma to the iris.
机译:我们报告了一例从食管腺癌中分离出的虹膜转移病例,该病例已通过局部应用立体定向放射治疗(SBRT)和玻璃体内辅助治疗成功进行了处理。一名53岁的局部晚期食管腺癌患者在手术和化疗后获得了完全的临床和放射学反应。 4个月后,他出现头痛,视力下降,通过裂隙灯检查被诊断出转移至虹膜。视力下降是继发于黄斑囊样水肿。 SBRT以及贝伐单抗和曲安西龙的玻璃体内注射后,转移性肿瘤和患者症状得以缓解。我们得出的结论是,SBRT联合玻璃体内化疗是一种有效且耐受良好的姑息治疗,可用于食管腺癌转移至虹膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号